Results 191 to 200 of about 1,349,045 (346)

Local intratracheal delivery of perfluorocarbon nanoparticles to lung cancer demonstrated with magnetic resonance multimodal imaging [PDF]

, 2018
Chen, Junjie, Lanza, Gregory M, Schmieder, Anne H, Shen, Baozhong, Stacy, Allen J, Sun, Xilin, Wang, Chunan, Wang, Kai, Wang, Xiance, Wen, Xiaofei, Williams, Todd, Wu, Lina, Zhang, Huiying   +12 more
core   +2 more sources

A Unified Whole Lung PBK Model for Inhalational Uptake of Gases and Aerosols in Men

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Assessing the risk or benefit of an inhaled substance is challenging due to the variety of forms it can take (gas, vapor, particle, or droplet) and the complex biological processes involved in its uptake and retention. Physiologically based kinetic (PBK) models offer an alternative to in vivo experiments.
Norman Nowak, Sylvia E. Escher, Katharina Schwarz   +2 more
wiley   +1 more source

Mel—Personal Reminiscence*

Frontiers in Pediatrics, 2014
H William Taeusch
doaj   +1 more source

Population Pharmacokinetics and Exposure‐Response Model‐Based Bayesian Extrapolation of FVC‐Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Nintedanib reduces the rate of decline in forced vital capacity (FVC) in adult patients with idiopathic pulmonary fibrosis (IPF), chronic progressive‐fibrosing interstitial lung diseases (ILDs) and systemic sclerosis‐associated ILD (SSc‐ILD).
Sonja Hartmann, Anna Chan Kwong, Jakob Ribbing, Martina Gahlemann, Julia Korell   +4 more
wiley   +1 more source

Prospective, Non-Blinded, Randomized Controlled Trial of Pulmonary Surfactant Administration Guided by Lung Ultrasound in Preterm Infants with Gestational Age < 32 Weeks [PDF]

Jinghui Zhang, Jinfang Yuan, Jing Xu, Tongyan Han, Yahui Zhang, Huiqiang Liu, Danfang Lu, Yunfeng Liu   +7 more
openalex   +1 more source

Engineering of pulmonary surfactant corona on inhaled nanoparticles to operate in the lung system

, 2023
Mojtaba Falahati, Anwarul Hasan, Hojjat Alizadeh Zeinabad, Vahid Serpooshan, Jan H. von der Thüsen, Timo L.M. ten Hagen   +5 more
openalex   +2 more sources

Data on the cytotoxicity of surfactants used to increase the dispersion of micro- and nanoplastics. [PDF]

Data Brief
Vercauteren M, Peng M, Seghers J, Semmouri I, Emteborg H, Janssen CR, Asselman J.   +6 more
europepmc   +1 more source

Reversibility of Pulmonary Abnormalities by Conditional Replacement of Surfactant Protein D (SP-D) in Vivo [PDF]

, 2002
Liqian Zhang, Machiko Ikegami, Chitta R. Dey, Thomas R. Korfhagen, Jeffrey A. Whitsett   +4 more
openalex   +1 more source

Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study

, 2022
Komal Malik, Susana Díaz‐Coto, Maria Jose de la Asunción Villaverde, Pablo Martínez‐Camblor, Annie Navarro, Francisco Pujalte, Alejandro de la Sierra, Pere Almagro   +7 more
openalex   +2 more sources

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

Phytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee, Yu Jin So, Il‐Joo Jo, Ji Yong Jang, Tae Han Yook, Jun Ho Lee, Sung Wook Kim, Kangwook Lee, Soo Jung Park, Gabsik Yang   +9 more
wiley   +1 more source